•  •  Dark Mode

Your Interests & Preferences

I am a...

law firm lawyer
in-house company lawyer
litigation lawyer
law student
aspiring student

Website Look & Feel

 •  •  Dark Mode
Blog Layout

Save preferences

DSK, PDS act on $8m India Alternatives PE investment in Brinton Pharma

India Alternatives Investment Advisors Ltd. invested up to USD 8 million for a significant minority stake in Brinton Pharmaceuticals Limited. Brinton is focused on dermatology and has recently expanded into the paediatric dermatology and respiratory segments.
The Economic Times

DSK Legal advised India Alternatives Private Equity Fund led by a team of partner Hemang Parekh, principal associate Shahin Umani, senior associate Pooja Khanna and associate Supallab Chakraborty.

PDS Legal advised Brinton Pharmaceuticals Limited led by a team of partner Vihang Virkar, executive director Monika Deshmukh and associate Shivani Shah.


Deal value: INR 55.6 crores

No comments yet: share your views